Sterling Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $51.3M | Sell |
55,740
-5,607
| -9% | -$5.68M | 0.97% | 20 |
|
|
2025
Q4 | $65.9M | Buy |
61,347
+14,999
| +32% | +$14.3M | 1.07% | 13 |
|
|
2025
Q3 | $35.4M | Sell |
46,348
-5,400
| -10% | -$4.02M | 0.52% | 44 |
|
|
2025
Q2 | $40.3M | Buy |
51,748
+8,016
| +18% | +$6.23M | 0.57% | 41 |
|
|
2025
Q1 | $36.1M | Sell |
43,732
-2,535
| -5% | -$2.11M | 0.56% | 39 |
|
|
2024
Q4 | $35.7M | Buy |
46,267
+1,123
| +2% | +$930K | 0.49% | 46 |
|
|
2024
Q3 | $40M | Buy |
+45,144
| New | +$40.6M | 0.52% | 40 |
|
|
2019
Q3 | $5.85M | Buy |
52,333
+134
| +0.3% | +$14.9K | 0.06% | 226 |
|
|
2019
Q2 | $5.78M | Buy |
52,199
+222
| +0.4% | +$26.1K | 0.06% | 241 |
|
|
2019
Q1 | $6.75M | Sell |
51,977
-3,322
| -6% | -$404K | 0.07% | 211 |
|
|
2018
Q4 | $6.4M | Sell |
55,299
-102,623
| -65% | -$11.5M | 0.07% | 206 |
|
|
2018
Q3 | $16.9M | Sell |
157,922
-4,362
| -3% | -$436K | 0.15% | 150 |
|
|
2018
Q2 | $13.8M | Buy |
162,284
+115,625
| +248% | +$9.5M | 0.13% | 160 |
|
|
2018
Q1 | $3.61M | Sell |
46,659
-560
| -1% | -$45.1K | 0.03% | 283 |
|
|
2017
Q4 | $3.99M | Buy |
47,219
+1,814
| +4% | +$154K | 0.04% | 280 |
|
|
2017
Q3 | $3.88M | Buy |
45,405
+16,874
| +59% | +$1.38M | 0.04% | 270 |
|
|
2017
Q2 | $2.35M | Sell |
28,531
-242
| -0.8% | -$19.7K | 0.02% | 355 |
|
|
2017
Q1 | $2.42M | Sell |
28,773
-161
| -0.6% | -$12.9K | 0.02% | 337 |
|
|
2016
Q4 | $2.13M | Sell |
28,934
-1,972
| -6% | -$147K | 0.02% | 362 |
|
|
2016
Q3 | $2.48M | Sell |
30,906
-2,649
| -8% | -$212K | 0.02% | 343 |
|
|
2016
Q2 | $2.64M | Buy |
33,555
+2,935
| +10% | +$221K | 0.02% | 332 |
|
|
2016
Q1 | $2.21M | Sell |
30,620
-11,257
| -27% | -$852K | 0.02% | 356 |
|
|
2015
Q4 | $3.53M | Buy |
41,877
+7,155
| +21% | +$594K | 0.03% | 286 |
|
|
2015
Q3 | $2.91M | Sell |
34,722
-12,464
| -26% | -$1.05M | 0.03% | 301 |
|
|
2015
Q2 | $3.94M | Sell |
47,186
-1,295
| -3% | -$98.7K | 0.04% | 215 |
|
|
2015
Q1 | $3.52M | Buy |
48,481
+5,652
| +13% | +$402K | 0.03% | 228 |
|
|
2014
Q4 | $2.96M | Buy |
42,829
+1,015
| +2% | +$68.5K | 0.03% | 280 |
|
|
2014
Q3 | $2.71M | Buy |
41,814
+5,493
| +15% | +$348K | 0.03% | 280 |
|
|
2014
Q2 | $2.26M | Buy |
36,321
+4,961
| +16% | +$296K | 0.02% | 310 |
|
|
2014
Q1 | $1.85M | Buy |
31,360
+16,388
| +109% | +$915K | 0.02% | 356 |
|
|
2013
Q4 | $764K | Buy |
14,972
+290
| +2% | +$14.5K | 0.01% | 438 |
|
|
2013
Q3 | $739K | Buy |
14,682
+448
| +3% | +$23.5K | 0.01% | 300 |
|
|
2013
Q2 | $699K | Buy |
+14,234
| New | +$775K | 0.01% | 239 |
|
Other funds holding LLY
VCM
VPM
Sterling Capital Management's LLY Position: Q1 2026 in Review
Sterling Capital Management reduced its Eli Lilly (LLY) stake by 9.1% in Q1 2026, selling an estimated $5.68M and leaving 55,740 shares worth $51.3M. The position accounts for 0.97% of the portfolio, ranked #20.
Sterling Capital Management first reported a position in LLY in Q2 2013 and has held it in 33 quarters since. The position peaked at $65.9M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Sterling Capital Management held 55,740 shares of Eli Lilly worth $51.3M as of Q1 2026.
- Sterling Capital Management sold 5,607 Eli Lilly shares in Q1 2026, an estimated $5.68M.
- Eli Lilly made up 0.97% of Sterling Capital Management's portfolio in Q1 2026, its #20 holding.
- Sterling Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 33 quarters since.
- Sterling Capital Management's Eli Lilly position peaked at $65.9M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.